What's new

Orphan designation: diflunisal Treatment of ATTR amyloidosis, 21/06/2022 Positive

Orphan designation: diflunisal Treatment of ATTR amyloidosis, 21/06/2022 Positive

Apr 25, 2025 - 15:03
 0
Orphan designation: diflunisal Treatment of ATTR amyloidosis, 21/06/2022 Positive
Orphan designation: diflunisal Treatment of ATTR amyloidosis, 21/06/2022 Positive
Read More

Tags:

Previous Article

Orphan designation: (14S)-8-[3-(2-{dispiro[2.0.24.13]heptan-7-yl}ethoxy)-1H-pyra...

Next Article

Human medicines European public assessment report (EPAR): Alyftrek, deutivacafto...

Related Posts

Article 57 product data

Apr 26, 2025  0

Business process description for quality defect and non...

Apr 22, 2025  0

Summary of opinion: Adempas, 25/05/2025 Positive

Summary of opinion: Adempas, 25/05/2025 Positive

Apr 25, 2025  0